The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20004167: Marathon Fund Limited Partnership IV; International Utility Structures Inc.
20004166: SCI Systems, Inc.; OMX, Inc.
20004162: PMC-Sierra, Inc.; Quantum Effect Devices, Inc.
20004161: Centennial Fund VI, L.P.; Agilera.com, Inc.
20004160: Forstmann Little & Co. Equity Partnership VI; Forstmann Little & Co. Equity Partnership V, L.P.
20004159: Thayer Equity Investors IV, L.P.; EFTC Corporation
20004158: Microsoft Corporation; Michael S. Edell
20004155: Roland Siegfried Hinz and Lila Sullivan Hinz; Salem Communications Corporation
20004152: Lincolnshire Equity Fund II, L.P.; Timothy R. Fallon
20004151: PwC Global Investments B.V.; PwC Global Holdings B.V.
20004150: HMTF Bridge Partners, L.P.; Vetrix Business Solutions, Inc.
20004143: Lincolnshire Equity Fund II, L.P.; Alan Van Vliet
20004142: Media Metrix, Inc.; Jupiter Communications, Inc.
20004140: Land O'Lakes, Inc.; AgriBioTech, Inc.
20004136: Mine Safety Appliances Company; William T. McCutcheon
20004115: Bowater Incorporated; General Electric Company
20004056: David S. Smith; PSI Holding, L.L.C.
20004021: Texas Instruments Incorporated; Burr-Brown Corporation
Pfizer Inc., and Warner-Lambert Company
Final consent order permits Pfizer’s merger with Warner-Lambert Company and requires divestitures in several pharmaceutical markets including: Pfizer’s RID brand of head lice treatment; Pfizer’s antidepressant drug, Celexa; Warner’s Cognex, a drug used in the treatment of Alzheimer’s disease; and assets relating to the Epidermal Growth Factor receptor tryosine kinase inhibitor - drugs under development to treat solid cancerous tumors such as head and neck, non-small cell lung, breast, ovarian, pancreas and colorectal cancers.